YEVGENIY KHARITON to Diabetes Mellitus, Type 2
This is a "connection" page, showing publications YEVGENIY KHARITON has written about Diabetes Mellitus, Type 2.
Connection Strength
0.173
-
Dapagliflozin effects on lung fluid volumes in patients with heart failure and reduced ejection fraction: Results from the DEFINE-HF trial. Diabetes Obes Metab. 2021 06; 23(6):1426-1430.
Score: 0.091
-
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial. Circulation. 2019 10 29; 140(18):1463-1476.
Score: 0.082